Cagrilintide and semaglutide together drive record weight loss in global trial Semaglutide + Cagrilintide Combo Medical Weight Loss in Walnut Creek Cagrilintide Weight Loss Appetite Control and Fat Burning Support ACC 2026: Meta analysis supports CagriSema as superior first line therapy in obesity Clinical Trials Arena Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination Cagrilintide is a novel, long acting peptide designed to target multiple receptors involved in appetite regulation and energy balance. Unlike traditional weight loss medications that often target a single pathway, cagrilintide acts as